优化肌钙蛋白检测在肾功能不全患者急性心肌梗死诊断中的性能
结果显示肾功能越差,未调整肌钙蛋白切点的诊断性能越低,高敏肌钙蛋白T常规切点假阳性率高达68-93%,研究提出按eGFR分层设定切点以改善肾功能不全患者疑似AMI的分诊。
要点
- 肾功能不全患者中未调整肌钙蛋白切点诊断AMI假阳性率高。
- eGFR越低,肌钙蛋白诊断AMI的C统计量越差(eGFR>90为0.93,eGFR<15为0.81)。
- 将假阳性率限制在15%时,eGFR 45-60、30-45、15-30的hs-TnT切点分别为73、112、184 ng/L。
核心结论
- 未调整的肌钙蛋白切点诊断AMI的性能随肾功能恶化而下降。
- 建议考虑按eGFR分层设定肌钙蛋白切点,以支持肾功能不全患者疑似AMI更有效的分诊和早期管理。
研究设计与样本
- 按eGFR分层分析肌钙蛋白分布,用C统计量评估诊断性能,计算不同切点的检出率、假阳性率和阳性预测值。
主要发现
- 20.6%的患者eGFR<60 mL/min/1.73 m2,6.4%的患者诊断为AMI。
- 无AMI患者中,eGFR与肌钙蛋白呈反向对数线性关系。
- 诊断AMI的C统计量在eGFR>90患者中最佳(0.93),在eGFR<15患者中最差(0.81)。
- 高敏肌钙蛋白T常规切点14 ng/L下,eGFR 15-60 mL/min/1.73 m2患者的假阳性率为68-93%。
关键数值与推荐
- 将假阳性率限制在15%时,eGFR 45-60、30-45、15-30 mL/min/1.73 m2的eGFR特异性切点分别为73、112、184 ng/L。
- 上述切点对应的检出率分别为73%、70%、68%。
临床怎么用
- 对肾功能不全患者解读首次肌钙蛋白升高时,需考虑eGFR对肌钙蛋白基线的影响。
- 可参考eGFR特异性切点(如hs-TnT在eGFR 45-60用73 ng/L、30-45用112 ng/L、15-30用184 ng/L)以减少假阳性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Serum troponin measurement forms a cornerstone of acute myocardial infarction (AMI) diagnosis. A major challenge is interpretation of an elevated first troponin in patients with impaired renal function. We aimed to (1) evaluate the relationship between estimated glomerular filtration rate (eGFR) and first troponin, (2) characterise the performance of different troponin assays for diagnosing AMI and (3) derive eGFR-specific thresholds for potential clinical use. METHODS: We analysed the distribution of troponin values stratified by eGFR and AMI. Diagnostic performance was analysed using the C-statistic. Test detection rate, false positive rate and positive predictive value were calculated for different cut-offs. RESULTS: We included 221 175 patients between 2010 and 2017 from four acute tertiary care hospitals in London, UK, with a median age of 65 years (IQR 49-79). eGFR was<60 mL/min/1.73 m2 in 20.6% of patients and 6.4% of patients had a diagnosis of AMI. In patients without AMI, we observed an inverse log-linear relationship between eGFR and troponin. Diagnostic performance for AMI was best in patients with eGFR>90 (C-statistic 0.93) and worst in eGFR<15 (C-statistic 0.81). For high-sensitive troponin T, using the conventional cut-off of 14 ng/L, false positive rates ranged from 68-93% for eGFRs between 15 and 60 mL/min/1.73 m2. Restricting the false positive rate to 15% yields eGFR specific cut-offs of 73, 112 and 184 ng/L, with detection rates of 73%, 70% and 68% in patients with an eGFR of 45-60, 30-45 or 15-30 mL/min/1.73 m2. CONCLUSIONS: The diagnostic performance of an unadjusted troponin cut-off for AMI falls with worsening renal function. We propose consideration of eGFR specific cut-offs to support more effective triage and early management of suspected AMI in patients with renal impairment. TRIAL REGISTRATION NUMBER: NCT03507309.
引用
- Collard, Chen, Kaura, et al. Improving the diagnostic performance of troponin assays for acute myocardial infarction in renal impairment. Heart. 2026. PMID: 42264918. doi:10.1136/heartjnl-2025-327658
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。